• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒辅助增强肿瘤特异性免疫。II. 牛痘病毒反应性辅助性T细胞增强细胞毒性T淋巴细胞的诱导及对肿瘤抗原的抗体反应。

The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells.

作者信息

Shimizu Y, Fujiwara H, Ueda S, Wakamiya N, Kato S, Hamaoka T

出版信息

Eur J Immunol. 1984 Sep;14(9):839-43. doi: 10.1002/eji.1830140913.

DOI:10.1002/eji.1830140913
PMID:6236991
Abstract

The present study investigates the role of vaccinia virus-reactive helper T cells in causing enhanced induction of syngeneic tumor immunity. Vaccinia virus-reactive helper T cell activity capable of inducing the augmented generation of cytotoxic T lymphocyte (CTL) or antibody responses was generated in C3H/HeN mice by inoculating i.p. live virus. Immunization of these mice with vaccinia virus-infected syngeneic X5563 plasmacytoma or MH134 hapatoma cells led to augmented induction of immune resistance against the challenge with corresponding viable tumor cells when compared with the incidence of resistance observed in control mice not primed to vaccinia virus. In vitro cytotoxicity tests utilizing spleen cells and serum from mice which resulted in the augmented tumor resistance by virus help have revealed that spleen cells from C3H/HeN mice immune to the X5563 plasmacytoma exhibited appreciable anti-X5563 CTL activity, whereas serum from these mice failed to display any antibody response. In contrast, MH134-immune mice exhibited potent anti-MH134 antibody, but not CTL responses. Such an anti-tumor CTL or antibody response augmented by vaccinia virus-reactive helper T cells was found to be tumor specific. These results are discussed in the context of (a) the functional diversity of tumor antigens, and (b) mechanisms of virus help that are involved in various forms of augmented induction of syngeneic tumor immunity.

摘要

本研究调查了痘苗病毒反应性辅助性T细胞在增强同基因肿瘤免疫诱导中的作用。通过腹腔注射活病毒,在C3H/HeN小鼠中产生了能够诱导细胞毒性T淋巴细胞(CTL)增强生成或抗体反应的痘苗病毒反应性辅助性T细胞活性。与未用痘苗病毒致敏的对照小鼠中观察到的抗性发生率相比,用痘苗病毒感染的同基因X5563浆细胞瘤或MH134肝癌细胞免疫这些小鼠,可增强对相应活肿瘤细胞攻击的免疫抗性诱导。利用因病毒辅助而导致肿瘤抗性增强的小鼠的脾细胞和血清进行的体外细胞毒性试验表明,对X5563浆细胞瘤免疫的C3H/HeN小鼠的脾细胞表现出明显的抗X5563 CTL活性,而这些小鼠的血清未显示任何抗体反应。相反,对MH134免疫的小鼠表现出强效的抗MH134抗体,但没有CTL反应。发现由痘苗病毒反应性辅助性T细胞增强的这种抗肿瘤CTL或抗体反应具有肿瘤特异性。在(a)肿瘤抗原的功能多样性和(b)参与同基因肿瘤免疫各种形式增强诱导的病毒辅助机制的背景下讨论了这些结果。

相似文献

1
The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells.病毒辅助增强肿瘤特异性免疫。II. 牛痘病毒反应性辅助性T细胞增强细胞毒性T淋巴细胞的诱导及对肿瘤抗原的抗体反应。
Eur J Immunol. 1984 Sep;14(9):839-43. doi: 10.1002/eji.1830140913.
2
Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.针对肿瘤相关抗原(TAA)的辅助性T细胞:优先诱导参与抗TAA细胞毒性T淋巴细胞和抗体反应的辅助性T细胞活性。
J Immunol. 1986 Apr 1;136(7):2715-9.
3
The augmentation of tumor-specific immunity by virus help. I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses.病毒辅助增强肿瘤特异性免疫。I. 痘苗病毒反应性辅助性T细胞活性在增强细胞毒性T淋巴细胞诱导和抗体反应中的作用。
Eur J Immunol. 1984 Feb;14(2):171-5. doi: 10.1002/eji.1830140212.
4
T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.迟发型超敏反应(DTH)诱导过程中的T - T细胞相互作用:痘苗病毒反应性辅助性T细胞活性参与增强DTH反应的体内诱导及其在增强肿瘤特异性DTH反应中的应用。
J Immunol. 1985 Jan;134(1):108-13.
5
Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activity.利用牛痘病毒反应性辅助性T细胞活性建立肿瘤特异性免疫治疗模型。
Eur J Immunol. 1988 Nov;18(11):1773-8. doi: 10.1002/eji.1830181118.
6
Additional evidence for the augmented induction of tumor-specific resistance in vaccinia virus-primed mice by immunization with vaccinia virus-modulated syngeneic tumor cells.
Biken J. 1984 Mar;27(1):1-7.
7
The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.肿瘤特异性Lyt-1⁺2⁻ T细胞在体内清除肿瘤细胞中的作用。I. Lyt-1⁺2⁻ T细胞在实施体内免疫时不一定需要募集宿主的细胞毒性T细胞前体。
J Immunol. 1984 Sep;133(3):1671-6.
8
Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.三硝基苯基(TNP)反应性辅助性T细胞增强抗肿瘤免疫反应:TNP辅助细胞增强荷瘤小鼠脾细胞诱导肿瘤特异性Lyt-1+2- T细胞介导的迟发型超敏反应。
J Natl Cancer Inst. 1986 Dec;77(6):1267-72.
9
Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.增强的TNP反应性辅助性T细胞活性及其在诱导导致肿瘤消退的增强肿瘤免疫中的应用。
J Immunol. 1984 Mar;132(3):1571-7.
10
[Significance of priming of hosts with virus in the tumor-specific immunotherapy model utilizing virus-reactive helper T cell activity].[在利用病毒反应性辅助性T细胞活性的肿瘤特异性免疫治疗模型中用病毒对宿主进行预刺激的意义]
Nihon Gan Chiryo Gakkai Shi. 1989 May 20;24(5):1007-14.

引用本文的文献

1
Potential of oncolytic viruses in the treatment of multiple myeloma.溶瘤病毒在多发性骨髓瘤治疗中的潜力。
Oncolytic Virother. 2018 Feb 23;7:1-12. doi: 10.2147/OV.S136644. eCollection 2017.
2
Oncolytic viruses.溶瘤病毒
Invest New Drugs. 1999;17(4):375-86. doi: 10.1023/a:1006334404767.
3
Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state.荷瘤状态下抗肿瘤T细胞反应的调节机制。
Immunol Res. 1995;14(4):271-91. doi: 10.1007/BF02935625.
4
Membrane-bound complement regulatory activity is decreased on vaccinia virus-infected cells.痘苗病毒感染的细胞上膜结合补体调节活性降低。
Clin Exp Immunol. 1994 Oct;98(1):134-9. doi: 10.1111/j.1365-2249.1994.tb06619.x.
5
Clinical trial of attenuated vaccinia virus AS strain in the treatment of advanced adenocarcinoma. Report on two cases.减毒痘苗病毒AS株治疗晚期腺癌的临床试验。两例报告。
J Cancer Res Clin Oncol. 1987;113(1):95-8. doi: 10.1007/BF00389974.
6
Feasibility of UV-inactivated vaccinia virus in the modification of tumor cells for augmentation of their immunogenicity.紫外线灭活痘苗病毒用于修饰肿瘤细胞以增强其免疫原性的可行性。
Cancer Immunol Immunother. 1986;23(2):125-9. doi: 10.1007/BF00199818.
7
Infection of DBA/2 or C3H/HeJ mice by intraperitoneal injection of vaccinia virus elicits activated macrophages, cytolytic and cytostatic for S91-melanoma tumor cells.通过腹腔注射痘苗病毒感染DBA/2或C3H/HeJ小鼠,可引发对S91黑色素瘤肿瘤细胞具有细胞溶解和细胞抑制作用的活化巨噬细胞。
Cancer Immunol Immunother. 1986;22(3):197-203. doi: 10.1007/BF00200033.
8
Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates.有证据表明用牛痘黑色素瘤细胞裂解物(VMCL)治疗可能会提高II期黑色素瘤患者的生存率。用病毒裂解物治疗II期黑色素瘤。
Cancer Immunol Immunother. 1987;25(3):257-65. doi: 10.1007/BF00199156.
9
Sensitization of human tumor cells to homologous complement by vaccinia virus treatment.通过牛痘病毒处理使人类肿瘤细胞对同源补体敏感。
Cancer Immunol Immunother. 1987;25(1):7-9. doi: 10.1007/BF00199294.
10
Studies on the recovery from tolerance to tumor antigens. II. Accelerated recovery of tumor-specific effector T cells in tolerant mice by applying T-T cell interaction mechanism.肿瘤抗原耐受性恢复的研究。II. 通过应用T-T细胞相互作用机制加速耐受小鼠体内肿瘤特异性效应T细胞的恢复。
Cancer Immunol Immunother. 1987;24(2):121-6. doi: 10.1007/BF00205588.